Solventum (NYSE:SOLV – Free Report) had its price target boosted by Bank of America from $80.00 to $85.00 in a research report released on Wednesday,Benzinga reports.Bank of America currently ...

Shares of Solventum Corp. SOLV shed 4.42% to $79.75 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.59% to 5,954.50 ...

Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at ...

Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed.

ST. PAUL, Minn. - Solventum Corporation (NYSE:SOLV) reported fourth-quarter earnings that fell short of analyst expectations, sending shares down 2% in after-hours trading. The healthcare technology ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1 ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 ...

ST. PAUL, Minn. - Solventum Corporation (NYSE:SOLV) reported fourth-quarter earnings that fell short of analyst expectations, sending shares down 2% in after-hours trading. The healthcare ...

*Data in the schedule above is intentionally rounded to the nearest million and, therefore, may not sum. (a) Consists of severance associated with restructuring programs. (b) Consists ...

MAPLEWOOD, Minn. (AP) — MAPLEWOOD, Minn. (AP) — Solventum Corp. (SOLV) on Thursday reported fourth-quarter net income of $30 million. The Maplewood, Minnesota-based company said it had net ...

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. ("Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) ("Solventum” or the "Company”) and is the Company's ...